156 related articles for article (PubMed ID: 35775461)
1. Long-term risk of uterine malignancies in women with uterine fibroids confirmed by myomectomy: a population-based study.
Yuk JS; Kim M
J Obstet Gynaecol; 2022 Oct; 42(7):3067-3072. PubMed ID: 35775461
[TBL] [Abstract][Full Text] [Related]
2. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
3. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
Mettler L; Abdusattarova K; Alkatout I
Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
[TBL] [Abstract][Full Text] [Related]
4. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
5. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.
Davis MR; Soliman AM; Castelli-Haley J; Snabes MC; Surrey ES
J Womens Health (Larchmt); 2018 Oct; 27(10):1204-1214. PubMed ID: 30085898
[TBL] [Abstract][Full Text] [Related]
6. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.
Pados G; Tsolakidis D; Theodoulidis V; Makedos A; Zaramboukas T; Tarlatzis B
Hum Reprod; 2017 Oct; 32(10):2036-2041. PubMed ID: 28938732
[TBL] [Abstract][Full Text] [Related]
8. Myomectomy: technique and current indications.
Wong L; Brun JL
Minerva Ginecol; 2014 Feb; 66(1):35-47. PubMed ID: 24569403
[TBL] [Abstract][Full Text] [Related]
9. Surgical removal of intramural fibroids improves the TNF-α induced inflammatory events in endometrium.
Kali Z; Cagiran FT
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(24):9180-9186. PubMed ID: 36591830
[TBL] [Abstract][Full Text] [Related]
10. Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry.
Laughlin-Tommaso SK; Lu D; Thomas L; Diamond MP; Wallace K; Wegienka G; Vines AI; Anchan RM; Wang T; Maxwell GL; Jacoby V; Marsh EE; Spies JB; Nicholson WK; Stewart EA; Myers ER
Am J Obstet Gynecol; 2020 Apr; 222(4):345.e1-345.e22. PubMed ID: 31678093
[TBL] [Abstract][Full Text] [Related]
11. Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy.
Wright JD; Tergas AI; Cui R; Burke WM; Hou JY; Ananth CV; Chen L; Richards C; Neugut AI; Hershman DL
JAMA Oncol; 2015 Apr; 1(1):69-77. PubMed ID: 26182307
[TBL] [Abstract][Full Text] [Related]
12. Malignancy rate of 10,731 uteri morcellated during laparoscopic supracervical hysterectomy (LASH).
Bojahr B; De Wilde RL; Tchartchian G
Arch Gynecol Obstet; 2015 Sep; 292(3):665-72. PubMed ID: 25820974
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and management experience of unexpected uterine sarcoma after myomectomy.
Zhang J; Zhang J; Dai Y; Zhu L; Lang J; Leng J
Int J Gynaecol Obstet; 2015 Aug; 130(2):195-9. PubMed ID: 26117552
[TBL] [Abstract][Full Text] [Related]
14. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
15. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
Zullo F; Venturella R; Raffone A; Saccone G
Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
[TBL] [Abstract][Full Text] [Related]
16. Uterine Sarcomas in Patients Undergoing Surgery for Presumed Leiomyomas: 10 Years' Experience.
Paul PG; Rengaraj V; Das T; Garg R; Thomas M; Khurd AS
J Minim Invasive Gynecol; 2016; 23(3):384-9. PubMed ID: 26677821
[TBL] [Abstract][Full Text] [Related]
17. A clinical audit of the patterns of presentations and complications of abdominal myomectomy at the University College Hospital, Ibadan, Nigeria.
Agboola AD; Bello OO; Olayemi OO
J Obstet Gynaecol; 2021 Oct; 41(7):1145-1150. PubMed ID: 33459101
[TBL] [Abstract][Full Text] [Related]
18. The management of uterine fibroids in women with otherwise unexplained infertility.
Carranza-Mamane B; Havelock J; Hemmings R; ;
J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
[TBL] [Abstract][Full Text] [Related]
19. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
